Desktop Site
|
26 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,730.16
-609.28
-0.82 %
Corporate Announcement
Security Code
532523
Company
Biocon Ltd
Exchange Received Time
29/04/2021 00:02:24
Exchange Disseminated Time
29/04/2021 00:02:28
Time Taken
00:00:04
Announcement under Regulation 30 (LODR)-Press Release / Media Release |
4/29/2021 12:02:26 AM
Biocon Q4FY21 Revenue at Rs 2,044 Cr, Up 26%; EBITDA at Rs 641 Cr; Up 68% Net Profit (before exceptional item & discontinuing operations) at Rs 257 Cr; Biosimilars Up 53% at Rs 664Cr; Research Services Up 8% at Rs 659 Cr; Generics Up 3% at Rs 578 Cr., FY21 Revenue Up 14% at Rs 7,360 Cr; EBITDA Up 8% at Rs 1,907 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 754 Cr.
Attachment
<< Back
Recently Viewed